Gene Solutions Secures Patent for Platform Technology Targeting Mitochondrial Dysfunction in Neurological Diseases

Gene Solutions, a leader in mitochondrial dysfunction genomics and CNS drug discovery, announces the publication of its platform technology patent. The a...

September 12, 2025 | Friday | News
Scipher Medicine and Maxymune Therapeutics Partner to Advance AI-Driven Target Discovery in Immunology

Scipher Medicine, a pioneer in network-based and AI-driven precision immunology,  announced a strategic collaboration with Maxymune Therapeutics, a ...

September 11, 2025 | Thursday | News
QIAGEN Secures CE-IVDR Certification for Full QIAstat-Dx Portfolio, Expands Syndromic Testing Panels

Full portfolio of QIAstat-Dx panels now CE-IVDR certified for use in clinical syndromic testing, underscoring commitment to highest-quality diagnosti...

September 11, 2025 | Thursday | News
Cytiva Joins Forces with WhiteLab Genomics to Shorten AAV Development Timelines

Collaboration will help reduce stable cell line development timelines in AAV genomic medicine development and ultimately also shorten development timeline ...

September 11, 2025 | Thursday | News
Trethera Completes Enrollment in Phase 1 Trial of TRE-515 for Advanced Solid Tumors

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

September 11, 2025 | Thursday | News
Greenwich LifeSciences Secures FDA Fast Track Designation for GLSI-100 in Breast Cancer

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-0...

September 11, 2025 | Thursday | News
Sapio Sciences and Ultima Genomics Forge Strategic Partnership to Streamline Multi-Omics Research

Sapio Sciences, the science-awareTM lab informatics platform,  announced a strategic partnership with Ultima Genomics. The collaboration will make m...

September 10, 2025 | Wednesday | News
Promega Partners with Watchmaker Genomics to Advance Reverse Transcriptase Technology

Partnership delivers advanced reverse transcriptase technology to enhance sensitivity, robustness and reproducibility of molecular analysis in clinical, ap...

September 10, 2025 | Wednesday | News
Tolerance Bio and ZipCode Bio Forge Strategic Collaboration to Develop Targeted RNA-Based Thymus Therapeutics

Tolerance Bio, a biopharmaceutical company pioneering innovative approaches to extending healthspan by preserving, restoring, and manipulating the functi...

September 09, 2025 | Tuesday | News
IFF Expands LMR Naturals Site in Grasse with €10 Million Investment to Drive Next-Generation Natural Ingredient Innovation

-IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences,  inaugurated its expanded LMR Naturals site in Grasse fo...

September 09, 2025 | Tuesday | News
Junshi Biosciences’ IL-17A Antibody JS005 Achieves Positive Phase 3 Results in Moderate-to-Severe Plaque Psoriasis

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to th...

September 08, 2025 | Monday | News
Johnson & Johnson’s RYBREVANT® Plus LAZCLUZE® Demonstrates Superior Resistance Prevention Over Osimertinib in EGFR-Mutated Lung Cancer

Johnson & Johnson announced new analyses from the Phase 3 MARIPOSA study demonstrating that first-line treatment with RYBREVANT® (amivantamab-vmj...

September 08, 2025 | Monday | News
CrystalsFirst and NexMR Forge Exclusive Partnership to Accelerate Fragment-Based Drug Discovery

 CrystalsFirst GmbH, a leader in high-performance structural biology services, and NexMR AG, a pioneer in ultrafast NMR screening,  announ...

September 05, 2025 | Friday | News
Andelyn Biosciences Partners with Tern Therapeutics to Advance Late-Stage Manufacturing of Gene Therapy for CLN2 Batten Disease

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered...

September 05, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close